Contact
Please use this form to send email to PR contact of this press release:
CytoDyn Completes Enrollment for Phase 3 Registrational Trial for 390 Patients with Severe-to-Critical COVID-19
TO:
Please use this form to send email to PR contact of this press release:
CytoDyn Completes Enrollment for Phase 3 Registrational Trial for 390 Patients with Severe-to-Critical COVID-19
TO: